close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard
Home・Aandelen Lijst・Groupe Bruxelles Lambert SA
Search

Groupe Bruxelles Lambert SA

Open

SectorFinanciën

75.7 -0.46

Prijsupdate 31 dec 2025, 12:51 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

75.65

Max

75.8

Belangrijke statistieken

By Trading Economics

Inkomsten

-50M

44M

Verkoop

34M

1.7B

K/W

Sectorgemiddelde

74.703

25.743

Winstmarge

2.578

EBITDA

-123M

199M

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-270M

9.1B

Vorige openingsprijs

76.16

Vorige sluitingsprijs

75.7

Nieuwssentiment

By Acuity

50%

50%

154 / 526 Rangschikking in Finance

Groupe Bruxelles Lambert SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 dec 2025, 22:20 UTC

Belangrijke Marktbewegers

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

DJ

Lezen

31 dec 2025, 17:31 UTC

Belangrijke Marktbewegers

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

DJ

Lezen

31 dec 2025, 16:30 UTC

Belangrijke Marktbewegers

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

DJ

Lezen

31 dec 2025, 15:19 UTC

Belangrijke Marktbewegers

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

DJ

Lezen

31 dec 2025, 15:17 UTC

Belangrijke Marktbewegers

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

DJ

Lezen

31 dec 2025, 14:37 UTC

Belangrijke Marktbewegers

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

DJ

Lezen

31 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

31 dec 2025, 21:13 UTC

Acquisities, Fusies, Overnames

10 People to Watch in Wealth Management in 2026 -- Barrons.com

DJ

Lezen

31 dec 2025, 20:40 UTC

Marktinformatie

Dollar Posting Its Worst Year Since 2017 -- Market Talk

DJ

Lezen

31 dec 2025, 20:22 UTC

Marktinformatie

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

DJ

Lezen

31 dec 2025, 19:50 UTC

Marktinformatie

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

DJ

Lezen

31 dec 2025, 19:31 UTC

Marktinformatie

Precious Metals Cap Off Record Runs -- Market Talk

DJ

Lezen

31 dec 2025, 18:50 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

31 dec 2025, 18:50 UTC

Marktinformatie

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

DJ

Lezen

31 dec 2025, 17:17 UTC

Marktinformatie

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

DJ

Lezen

31 dec 2025, 17:16 UTC

Belangrijke Marktbewegers

OwlTing Climbs on Launch of $10M Stock-Buyback Program

DJ

Lezen

31 dec 2025, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

DJ

Lezen

31 dec 2025, 17:00 UTC

Acquisities, Fusies, Overnames

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

DJ

Lezen

31 dec 2025, 15:57 UTC

Acquisities, Fusies, Overnames

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

DJ

Lezen

31 dec 2025, 15:54 UTC

Marktinformatie

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

DJ

Lezen

31 dec 2025, 15:02 UTC

Belangrijke Marktbewegers

Nike Shares Rise After CEO Hill Buys $1M of Shares

DJ

Lezen

31 dec 2025, 14:40 UTC

Acquisities, Fusies, Overnames

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

DJ

Lezen

31 dec 2025, 14:20 UTC

Marktinformatie

Crude Futures On Track to End the Year With Losses -- Market Talk

DJ

Lezen

31 dec 2025, 13:46 UTC

Marktinformatie

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

DJ

Lezen

31 dec 2025, 13:01 UTC

Winsten
Acquisities, Fusies, Overnames

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

DJ

Lezen

31 dec 2025, 11:10 UTC

Marktinformatie

Copper Remains in Touching Distance of Record Highs -- Market Talk

DJ

Lezen

31 dec 2025, 10:46 UTC

Marktinformatie

Euro on Track For Strong Annual Performance -- Market Talk

DJ

Lezen

31 dec 2025, 10:25 UTC

Marktinformatie

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

DJ

Lezen

31 dec 2025, 10:23 UTC

Marktinformatie

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

DJ

Lezen

31 dec 2025, 09:33 UTC

Marktinformatie

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

DJ

Lezen

Groupe Bruxelles Lambert SA Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Gebaseerd op 0 analisten die aandelenratings hebben gegeven aan Groupe Bruxelles Lambert SA - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

154 / 526 Rangschikking in Financiën

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Groupe Bruxelles Lambert SA

Groupe Bruxelles Lambert SA invests in a portfolio of industrial, consumer goods, and business service companies operating in various sectors in Belgium, other European countries, North America, and internationally. The company operates through seven segments: Holding, Imerys, Webhelp, Canyon, Affidea, Sanoptis, and GBL Capital and Sienna Investment Managers. Groupe Bruxelles Lambert SA was incorporated in 1902 and is based in Brussels, Belgium.
help-icon Live chat